GlassScriptPhysician profile
David W Barton
NPI 1013478403
$18,016.01
in general payments reported to CMS, 2019-2025
12 companies · $9,355 in 2025
The $9,355 reported for 2025 was more than what 77% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $305 · 2021: $330 · 2022: $334 · 2023: $413 · 2024: $7,278 · 2025: $9,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $11K · Travel and Lodging: $2,667 · Food and Beverage: $2,510 · Education: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $11,350.00 |
| Travel and Lodging | $2,666.90 |
| Food and Beverage | $2,510.17 |
| Education | $519.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,135.95 | 2024-2025 | Evos |
| Medical Device Business Services, INC. | $2,838.94 | 2020-2024 | |
| Synthes Gmbh | $2,666.90 | 2025 | |
| Depuy Synthes Sales INC. | $893.36 | 2024-2025 | Na, Va-Lcp, Motoband |
| Stryker Corporation | $436.55 | 2024-2025 | Pangea, T2 Alpha |
| Acera Surgical, INC. | $311.36 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $146.63 | 2024 | Unid_pass |
| Kerecis Limited | $139.29 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Amgen INC. | $125.01 | 2025 | |
| Medinc of Texas | $115.32 | 2025 | |
| Elite Orthopedics, LLC | $103.50 | 2025 | |
| Paragon 28, INC. | $103.20 | 2023 | Portfolio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.